{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:12:57Z","timestamp":1777281177015,"version":"3.51.4"},"reference-count":105,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Allergy"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Mast cell disorders (MCD), including mastocytosis and mast cell (MC) activation syndrome (MCAS), encompass a heterogeneous spectrum of diseases often presenting with debilitating manifestations. Variable clinical manifestations, ranging from otherwise asymptomatic cutaneous forms to recurrent anaphylaxis, pose significant challenges for timely diagnosis and effective management. Despite increasing recognition of MCD in Europe, diagnosis is frequently delayed, and therapeutic approaches remain inconsistent, potentially due to gaps and disparities in training. An European Academy of Allergy and Clinical Immunology (EAACI) Task Force (TF) was created to address this need. Through iterative consensus, the TF members formulated ten expert\u2010based recommendations outlining the minimum competencies that allergology and clinical immunology trainees should acquire regarding MCD. These include fundamental knowledge of MC biology, pathogenesis of clonality, recognition of systemic manifestations, diagnostic methodologies, pharmacological and preventive strategies, management of comorbid Hymenoptera venom allergy, pediatric aspects, communication skills, and how to acquire and consolidate expertise. This position paper underscores the need for harmonized competency\u2010based training competencies on MCD for Allergists and Clinical Immunologists across Europe. We advocate for the incorporation of these recommendations into national postgraduate curricula, aiming to foster earlier recognition, improve management, and ultimately enhance long\u2010term outcomes for MCD patients.<\/jats:p>","DOI":"10.1111\/all.70344","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:25:57Z","timestamp":1777278357000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Definition of Competencies for Allergology Specialty\/Subspecialty Training in Mast Cell Disorders in Europe: An\u00a0\n                    <scp>EAACI<\/scp>\n                    Position Paper"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-617X","authenticated-orcid":false,"given":"Tiago Azenha","family":"Rama","sequence":"first","affiliation":[{"name":"Servi\u00e7o de Imunoalergologia Unidade Local de Sa\u00fade de Matosinhos  Matosinhos Portugal"},{"name":"Servi\u00e7o de Imunologia Faculdade de Medicina da Universidade do Porto  Porto Portugal"}]},{"given":"Theo","family":"Gulen","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Allergy Karolinska University Hospital, Huddinge  Stockholm Sweden"},{"name":"Department of Medicine Solna, Immunology and Allergy Unit Karolinska Institutet  Stockholm Sweden"}]},{"given":"Knut","family":"Brockow","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Biederstein School of Medicine and Health, TUM University Hospital Rechts der Isar  Munich Germany"},{"name":"Odense Research Center for Anaphylaxis (ORCA), Department of Dermatology and Allergy Centre Odense University Hospital  Odense Denmark"}]},{"given":"Patrizia","family":"Bonadonna","sequence":"additional","affiliation":[{"name":"Allergy Unit University Hospital, Azienda Ospedaliera Universitaria Integrata Verona  Verona Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-314X","authenticated-orcid":false,"given":"Vito","family":"Sabato","sequence":"additional","affiliation":[{"name":"Immunology Allergology Rheumatology University of Antwerp and Antwerp University Hospital  Antwerp Belgium"}]},{"given":"Clive E.","family":"Grattan","sequence":"additional","affiliation":[{"name":"St John's Institute of Dermatology  London UK"}]},{"given":"Sigurd","family":"Broesby\u2010Olsen","sequence":"additional","affiliation":[{"name":"Mastocytosis Centre, Odense University Hospital (MastOUH), Odense University Hospital  Odense Denmark"},{"name":"Department of Dermatology and Allergy Centre Odense University Hospital  Odense Denmark"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9955-385X","authenticated-orcid":false,"given":"Sabine","family":"Altrichter","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venerology Kepler University Hospital  Linz Austria"},{"name":"Clinical Research Institute for Inflammation Medicine, Medical Faculty Johannes Kepler University  Linz Austria"},{"name":"Institute of Allergology Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t Zu Berlin  Berlin Germany"},{"name":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergolgy, IA  Berlin Germany"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4532-1644","authenticated-orcid":false,"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[{"name":"Institute of Allergology Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t Zu Berlin  Berlin Germany"},{"name":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergolgy, IA  Berlin Germany"}]},{"given":"Jolanta","family":"Walusiak\u2010Skorupa","sequence":"additional","affiliation":[{"name":"Department of Occupational Diseases and Environmental Health Nofer Institute of Occupational Medicine  \u0141\u00f3d\u017a Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-4900","authenticated-orcid":false,"given":"David","family":"Gonz\u00e1lez\u2010de\u2010Olano","sequence":"additional","affiliation":[{"name":"Department of Allergy Hospital Ram\u00f3n y Cajal, IRYCIS  Madrid Spain"}]}],"member":"311","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"11","key":"e_1_2_12_2_1","article-title":"Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal","volume":"5","author":"Valent P.","year":"2021","journal-title":"Hema"},{"issue":"2","key":"e_1_2_12_3_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast Cells, Mastocytosis, and Related Disorders","volume":"373","author":"Theoharides T. C.","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"e_1_2_12_4_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","article-title":"The Mastocytosis Society Survey on Mast Cell Disorders: Patient Experiences and Perceptions","volume":"2","author":"Jennings S.","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"9","key":"e_1_2_12_5_1","first-page":"3121","article-title":"Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis","volume":"8","author":"Schwaab J.","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"8","key":"e_1_2_12_6_1","first-page":"2924","article-title":"Frequency of Clonal Mast Cell Diseases Among Patients Presenting With Anaphylaxis: A Prospective Study in 178 Patients From 5 Tertiary Centers in Spain","volume":"7","author":"Gonzalez\u2010de\u2010Olano D.","year":"2019","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"4","key":"e_1_2_12_7_1","first-page":"1125","article-title":"Proposed Diagnostic Algorithm for Patients With Suspected Mast Cell Activation Syndrome","volume":"7","author":"Valent P.","year":"2019","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"1","key":"e_1_2_12_8_1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2014.06.031","article-title":"Recognizing Mastocytosis in Patients With Anaphylaxis: Value of KIT D816V Mutation Analysis of Peripheral Blood","volume":"135","author":"Broesby\u2010Olsen S.","year":"2015","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/all.16084","article-title":"High Burden of Clonal Mast Cell Disorders and Hereditary Alpha\u2010Tryptasemia in Patients Who Need Hymenoptera Venom Immunotherapy","volume":"79","author":"Korosec P.","year":"2024","journal-title":"Allergy"},{"issue":"8","key":"e_1_2_12_10_1","doi-asserted-by":"crossref","DOI":"10.1007\/s11882-014-0450-8","article-title":"Anaphylaxis as a Clinical Manifestation of Clonal Mast Cell Disorders","volume":"14","author":"Matito A.","year":"2014","journal-title":"Current Allergy and Asthma Reports"},{"key":"e_1_2_12_11_1","volume-title":"Anaphylaxis and Hypersensitivity Reactions","author":"Escribano L.","year":"2011"},{"issue":"3","key":"e_1_2_12_12_1","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12132","article-title":"Mastocytosis Presenting With Mast Cell\u2010Mediator Release\u2010Associated Symptoms Elicited by Cyclo Oxygenase Inhibitors: Prevalence, Clinical, and Laboratory Features","volume":"12","author":"Rama T. A.","year":"2022","journal-title":"Clinical and Translational Allergy"},{"issue":"5","key":"e_1_2_12_13_1","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10050718","article-title":"COVID\u201019 Vaccination Is Safe Among Mast Cell Disorder Patients, Under Adequate Premedication","volume":"10","author":"Rama T. A.","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"e_1_2_12_14_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/all.15476","article-title":"Outcomes of COVID\u201019 Vaccination in 323 Patients With Clonal and Non\u2010Clonal Mast Cell Activation Disorders","volume":"78","author":"Giannetti M. P.","year":"2023","journal-title":"Allergy"},{"issue":"1","key":"e_1_2_12_15_1","first-page":"388","article-title":"Drug Hypersensitivity in Indolent Systemic Mastocytosis, Without Skin Lesions, Presenting With Anaphylaxis to Hymenoptera Venoms","volume":"76","author":"Rama T. A.","year":"2021","journal-title":"Allergy"},{"issue":"7","key":"e_1_2_12_16_1","first-page":"1850","article-title":"Drug\u2010Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts","volume":"12","author":"Beyens M.","year":"2024","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"3","key":"e_1_2_12_17_1","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jaci.2018.10.063","article-title":"Adverse Reactions to Drugs and Biologics in Patients With Clonal Mast Cell Disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology","volume":"143","author":"Carter M. C.","year":"2019","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.jaip.2020.05.044","article-title":"Low Frequency of IgE\u2010Mediated Food Hypersensitivity in Mastocytosis","volume":"8","author":"Jarkvist J.","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"key":"e_1_2_12_19_1","first-page":"3724","article-title":"Placebo\u2010Controlled Histamine Challenge Disproves Suspicion of Histamine Intolerance","volume":"11","author":"Bent R. K.","year":"2023","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"key":"e_1_2_12_20_1","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.1071807","article-title":"Non\u2010Steroidal Anti\u2010Inflammatory Drug\u2010Induced Anaphylaxis Infrequent in 388 Patients With Mastocytosis: A Two\u2010Center Retrospective Cohort Study","volume":"3","author":"Bonadonna P.","year":"2022","journal-title":"Frontiers in Allergy"},{"issue":"1","key":"e_1_2_12_21_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000436969","article-title":"Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures","volume":"167","author":"Matito A.","year":"2015","journal-title":"International Archives of Allergy and Immunology"},{"issue":"7","key":"e_1_2_12_22_1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.jaip.2024.05.010","article-title":"Drug\u2010Induced Anaphylaxis in Mastocytosis: A Cause for Concern?","volume":"12","author":"Jayasundera J.","year":"2024","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"3","key":"e_1_2_12_23_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2021.10.004","article-title":"Low Risk of Contrast Media\u2010Induced Hypersensitivity Reactions in All Subtypes of Systemic Mastocytosis","volume":"128","author":"Schwaab J.","year":"2022","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"e_1_2_12_24_1","unstructured":"Section U Board of Allergology \u201cEuropean Training Requirements for the Specialty of Allergology \u201dUnion Europ\u00e9enne des M\u00e9decins Sp\u00e9cialistes (2018)."},{"key":"e_1_2_12_25_1","unstructured":"Accreditation Council for Graduate Medical Education \u201cProgram Requirements for Graduate Medical Education in Allergy and Immunology. Accreditation Council for Graduate Medical Education \u201d(2025)."},{"issue":"2","key":"e_1_2_12_26_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","article-title":"Diagnostic Criteria and Classification of Mastocytosis in 2014","volume":"34","author":"Akin C.","year":"2014","journal-title":"Immunology and Allergy Clinics of North America"},{"key":"e_1_2_12_27_1","first-page":"291","volume-title":"World Health Organization (WHO) Classification of Tumours Pathology & Genetics Tumours of Haematopoietic and Lymphoid Tissues. 1","author":"Valent P.","year":"2001"},{"issue":"7","key":"e_1_2_12_28_1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury J. D.","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"e_1_2_12_29_1","first-page":"908","article-title":"Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality","volume":"11","author":"Rama T. A.","year":"2023","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"3","key":"e_1_2_12_30_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.iac.2018.04.010","article-title":"Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder","volume":"38","author":"Bonadonna P.","year":"2018","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"11","key":"e_1_2_12_31_1","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1016\/j.jaip.2021.06.011","article-title":"Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review","volume":"9","author":"Gulen T.","year":"2021","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"8","key":"e_1_2_12_32_1","first-page":"1941","article-title":"Global Classification of Mast Cell Activation Disorders: An ICD\u201010\u2010CM\u2010Adjusted Proposal of the ECNM\u2010AIM Consortium","volume":"10","author":"Valent P.","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"2","key":"e_1_2_12_33_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","article-title":"Mast Cell Activation Syndromes","volume":"140","author":"Akin C.","year":"2017","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"e_1_2_12_34_1","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jaip.2020.02.021","article-title":"The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome","volume":"8","author":"Butterfield J.","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"8","key":"e_1_2_12_35_1","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jaip.2023.02.017","article-title":"Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome","volume":"11","author":"Butterfield J. H.","year":"2023","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"21","key":"e_1_2_12_36_1","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13213307","article-title":"A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis","volume":"13","author":"Gulen T.","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"e_1_2_12_37_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features","volume":"38","author":"Lyons J. J.","year":"2018","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"5","key":"e_1_2_12_38_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11882-021-01010-1","article-title":"Hereditary Alpha\u2010Tryptasemia: A Commonly Inherited Modifier of Anaphylaxis","volume":"21","author":"Wu R.","year":"2021","journal-title":"Current Allergy and Asthma Reports"},{"issue":"4","key":"e_1_2_12_39_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.23822\/EurAnnACI.1764-1489.288","article-title":"Defining Hereditary Alpha\u2010Tryptasemia as a Risk\/Modifying Factor for Anaphylaxis: Are We There Yet?","volume":"55","author":"Couto M. L.","year":"2023","journal-title":"European Annals of Allergy and Clinical Immunology"},{"issue":"5","key":"e_1_2_12_40_1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-021-00622-y","article-title":"Understanding Human Mast Cells: Lesson From Therapies for Allergic and Non\u2010Allergic Diseases","volume":"22","author":"Kolkhir P.","year":"2022","journal-title":"Nature Reviews. Immunology"},{"issue":"23","key":"e_1_2_12_41_1","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.7150\/thno.46719","article-title":"Mast Cells as a Unique Hematopoietic Lineage and Cell System: From Paul Ehrlich's Visions to Precision Medicine Concepts","volume":"10","author":"Valent P.","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"e_1_2_12_42_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","article-title":"The Biology of Kit in Disease and the Application of Pharmacogenetics","volume":"114","author":"Akin C.","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"e_1_2_12_43_1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2015-07-655100","article-title":"KIT D816V\u2010Mutated Bone Marrow Mesenchymal Stem Cells in Indolent Systemic Mastocytosis Are Associated With Disease Progression","volume":"127","author":"Garcia\u2010Montero A. C.","year":"2016","journal-title":"Blood"},{"issue":"7","key":"e_1_2_12_44_1","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT Mutation in Mast Cells and Other Bone Marrow Hematopoietic Cell Lineages in Systemic Mast Cell Disorders: A Prospective Study of the Spanish Network on Mastocytosis (REMA) in a Series of 113 Patients","volume":"108","author":"Garcia\u2010Montero A. C.","year":"2006","journal-title":"Blood"},{"issue":"3","key":"e_1_2_12_45_1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in Adult Indolent Systemic Mastocytosis: A Long\u2010Term Study of the Spanish Network on Mastocytosis in a Series of 145 Patients","volume":"124","author":"Escribano L.","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"e_1_2_12_46_1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/path.2677","article-title":"Variable Presence of KITD816V in Clonal Haematological Non\u2010Mast Cell Lineage Diseases Associated With Systemic Mastocytosis (SM\u2010AHNMD)","volume":"220","author":"Sotlar K.","year":"2010","journal-title":"Journal of Pathology"},{"issue":"6","key":"e_1_2_12_47_1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2004.02.032","article-title":"Expression of Alpha\u2010Tryptase and Beta\u2010Tryptase by Human Basophils","volume":"113","author":"Jogie\u2010Brahim S.","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"e_1_2_12_48_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.iac.2006.05.005","article-title":"Mast Cells Mediators in Allergic Inflammation and Mastocytosis","volume":"26","author":"Castells M.","year":"2006","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"6","key":"e_1_2_12_49_1","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","article-title":"The Genetic Basis and Clinical Impact of Hereditary Alpha\u2010Tryptasemia","volume":"9","author":"Luskin K. T.","year":"2021","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"2","key":"e_1_2_12_50_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2024.05.025","article-title":"Mast Cell Activation Syndrome: Current Understanding and Research Needs","volume":"154","author":"Castells M.","year":"2024","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"e_1_2_12_51_1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, Biological, and Molecular Characteristics of Clonal Mast Cell Disorders Presenting With Systemic Mast Cell Activation Symptoms","volume":"125","author":"Alvarez\u2010Twose I.","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"e_1_2_12_52_1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","article-title":"The Presence of Mast Cell Clonality in Patients With Unexplained Anaphylaxis","volume":"44","author":"Gulen T.","year":"2014","journal-title":"Clinical and Experimental Allergy"},{"key":"e_1_2_12_53_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117141","article-title":"Underlying Systemic Mastocytosis in Patients With Unexplained Osteoporosis: Score Proposal","volume":"186","author":"Tanasi I.","year":"2024","journal-title":"Bone"},{"issue":"3","key":"e_1_2_12_54_1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2017.277897","article-title":"Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis","volume":"64","author":"Greiner G.","year":"2018","journal-title":"Clinical Chemistry"},{"issue":"2","key":"e_1_2_12_55_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved Detection of the KIT D816V Mutation in Patients With Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real\u2010Time qPCR Assay","volume":"13","author":"Kristensen T.","year":"2011","journal-title":"Journal of Molecular Diagnostics"},{"key":"e_1_2_12_56_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaci.2025.10.010","article-title":"Prevalence of KIT D816V in Anaphylaxis or Systemic Mast Cell Activation","volume":"157","author":"Hartmann K.","year":"2026","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"22","key":"e_1_2_12_57_1","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1182\/blood.2025029507","article-title":"Improved Diagnostic Screening and Classification of Clonal Mast Cell Diseases by Ultrasensitive KIT p.D816V Detection","volume":"146","author":"Navarro\u2010Navarro P.","year":"2025","journal-title":"Blood"},{"issue":"1","key":"e_1_2_12_58_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A Distinct Biomolecular Profile Identifies Monoclonal Mast Cell Disorders in Patients With Idiopathic Anaphylaxis","volume":"141","author":"Carter M. C.","year":"2018","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"7","key":"e_1_2_12_59_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071420","article-title":"Bone Marrow Mastocytosis: A Diagnostic Challenge","volume":"10","author":"Zanotti R.","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"8","key":"e_1_2_12_60_1","first-page":"1999","article-title":"Personalized Management Strategies in Mast Cell Disorders: ECNM\u2010AIM User's Guide for Daily Clinical Practice","volume":"10","author":"Valent P.","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"4","key":"e_1_2_12_61_1","first-page":"1705","article-title":"Scoring the Risk of Having Systemic Mastocytosis in Adult Patients With Mastocytosis in the Skin","volume":"9","author":"Fuchs D.","year":"2021","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"2","key":"e_1_2_12_62_1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary Alpha Tryptasemia Is Not Associated With Specific Clinical Phenotypes","volume":"149","author":"Chollet M. B.","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"e_1_2_12_63_1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary Alpha\u2010Tryptasemia in 101 Patients With Mast Cell Activation\u2010Related Symptomatology Including Anaphylaxis","volume":"126","author":"Giannetti M. P.","year":"2021","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"5","key":"e_1_2_12_64_1","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/ijms22052458","article-title":"Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond","volume":"22","author":"Sprinzl B.","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"e_1_2_12_65_1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/all.15911","article-title":"Clinical Impact of the TPSAB1 Genotype in Mast Cell Diseases: A REMA Study in a Cohort of 959 Individuals","volume":"79","author":"Gonzalez\u2010de\u2010Olano D.","year":"2024","journal-title":"Allergy"},{"issue":"8","key":"e_1_2_12_66_1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jaip.2022.03.001","article-title":"Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU\u2010US Cooperative Group","volume":"10","author":"Hoermann G.","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"5","key":"e_1_2_12_67_1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/all.15584","article-title":"KITD816V Mutation in Blood for the Diagnostic Screening of Systemic Mastocytosis and Mast Cell Activation Syndromes","volume":"78","author":"Navarro\u2010Navarro P.","year":"2023","journal-title":"Allergy"},{"issue":"8","key":"e_1_2_12_68_1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","article-title":"Detection of the KIT D816V Mutation in Peripheral Blood of Systemic Mastocytosis: Diagnostic Implications","volume":"28","author":"Jara\u2010Acevedo M.","year":"2015","journal-title":"Modern Pathology"},{"issue":"1","key":"e_1_2_12_69_1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.2012.01789.x","article-title":"Circulating KIT D816V Mutation\u2010Positive Non\u2010Mast Cells in Peripheral Blood Are Characteristic of Indolent Systemic Mastocytosis","volume":"89","author":"Kristensen T.","year":"2012","journal-title":"European Journal of Haematology"},{"issue":"2","key":"e_1_2_12_70_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/ejh.12128","article-title":"Serum Tryptase Correlates With the KIT D816V Mutation Burden in Adults With Indolent Systemic Mastocytosis","volume":"91","author":"Kristensen T.","year":"2013","journal-title":"European Journal of Haematology"},{"issue":"5","key":"e_1_2_12_71_1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.2018886507","article-title":"Frequency and Prognostic Impact of KIT and Other Genetic Variants in Indolent Systemic Mastocytosis","volume":"134","author":"Munoz\u2010Gonzalez J. I.","year":"2019","journal-title":"Blood"},{"key":"e_1_2_12_72_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-0716-0696-4_27","article-title":"Identification and Immunophenotypic Characterization of Normal and Pathological Mast Cells","volume":"2163","author":"Morgado J. M.","year":"2020","journal-title":"Methods in Molecular Biology"},{"issue":"8","key":"e_1_2_12_73_1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/jdv.18143","article-title":"Validation of Dermatopathological Criteria to Diagnose Cutaneous Lesions of Mastocytosis: Importance of KIT D816V Mutation Analysis","volume":"36","author":"Gebhard J.","year":"2022","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"e_1_2_12_74_1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PAS.0000000000000190","article-title":"A Clinicopathologic Study of 24 Cases of Systemic Mastocytosis Involving the Gastrointestinal Tract and Assessment of Mucosal Mast Cell Density in Irritable Bowel Syndrome and Asymptomatic Patients","volume":"38","author":"Doyle L. A.","year":"2014","journal-title":"American Journal of Surgical Pathology"},{"issue":"7","key":"e_1_2_12_75_1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha\u2010Tryptasemia and Mast Cell Activation Syndrome","volume":"45","author":"Hamilton M. J.","year":"2021","journal-title":"American Journal of Surgical Pathology"},{"issue":"4","key":"e_1_2_12_76_1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.iac.2023.04.005","article-title":"Gastrointestinal Disease in Mastocytosis","volume":"43","author":"Hamilton M. J.","year":"2023","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"6","key":"e_1_2_12_77_1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaci.2015.04.024","article-title":"Assessment of Clinical Findings, Tryptase Levels, and Bone Marrow Histopathology in the Management of Pediatric Mastocytosis","volume":"136","author":"Carter M. C.","year":"2015","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"e_1_2_12_78_1","article-title":"Well\u2010Differentiated Systemic Mastocytosis: A New Disease Variant With Mature Mast Cell Phenotype and Lack of Codon 816 c\u2010Kit Mutations","volume":"113","author":"Akin C.","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"e_1_2_12_79_1","first-page":"2139","article-title":"COVID\u201019 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)","volume":"9","author":"Bonadonna P.","year":"2021","journal-title":"Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"6","key":"e_1_2_12_80_1","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jaci.2022.04.020","article-title":"Tyrosine Kinase Inhibitors for the Treatment of Indolent Systemic Mastocytosis: Are We There Yet?","volume":"149","author":"Akin C.","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"11","key":"e_1_2_12_81_1","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/all.12920","article-title":"Patient\u2010Reported Disease\u2010Specific Quality\u2010Of\u2010Life and Symptom Severity in Systemic Mastocytosis","volume":"71","author":"Anrooij B.","year":"2016","journal-title":"Allergy"},{"issue":"7","key":"e_1_2_12_82_1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/all.13425","article-title":"Development and Validation of the Mastocytosis Activity Score","volume":"73","author":"Siebenhaar F.","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"e_1_2_12_83_1","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-02035-5","article-title":"Development of Symptom\u2010Focused Outcome Measures for Advanced and Indolent Systemic Mastocytosis: The AdvSM\u2010SAF and ISM\u2010SAF((c))","volume":"16","author":"Taylor F.","year":"2021","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"6","key":"e_1_2_12_84_1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/all.12842","article-title":"Development and Validation of the Mastocytosis Quality of Life Questionnaire: MC\u2010QoL","volume":"71","author":"Siebenhaar F.","year":"2016","journal-title":"Allergy"},{"issue":"2","key":"e_1_2_12_85_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.iac.2014.01.012","article-title":"Treatment Strategies in Mastocytosis","volume":"34","author":"Siebenhaar F.","year":"2014","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"4","key":"e_1_2_12_86_1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","article-title":"Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long\u2010Term Management","volume":"7","author":"Castells M.","year":"2019","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"6","key":"e_1_2_12_87_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.18176\/jiaci.0675","article-title":"Clinical Approach to Mast Cell Activation Syndrome: A Practical Overview","volume":"31","author":"Matito A.","year":"2021","journal-title":"Journal of Investigational Allergology and Clinical Immunology"},{"issue":"1","key":"e_1_2_12_88_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.32932\/rpia.2020.03.030","article-title":"Abordagem Diagn\u00f3stica e Terap\u00eautica das Mastocitoses \u2013 Uma Proposta de Orienta\u00e7\u00e3o Cl\u00ednica","volume":"28","author":"Rama T.","year":"2020","journal-title":"Revista Portuguesa de Imunoalergologia"},{"issue":"2","key":"e_1_2_12_89_1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI Guidelines: Anaphylaxis (2021 Update)","volume":"77","author":"Muraro A.","year":"2022","journal-title":"Allergy"},{"issue":"2","key":"e_1_2_12_90_1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaip.2024.10.044","article-title":"Safety and Low Incidence of Anaphylaxis in Performing Oral Drug and Food Challenges in Mastocytosis","volume":"13","author":"Bent R. K.","year":"2025","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"6","key":"e_1_2_12_91_1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0714.2010.00996.x","article-title":"Mastocytosis: Oral Implications of a Rare Disease","volume":"40","author":"Rama T. A.","year":"2011","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"1","key":"e_1_2_12_92_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High Prevalence of Anaphylaxis in Patients With Systemic Mastocytosis \u2013 A Single\u2010Centre Experience","volume":"44","author":"Gulen T.","year":"2014","journal-title":"Clinical and Experimental Allergy"},{"issue":"2","key":"e_1_2_12_93_1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive Systemic Mastocytosis (SM) Without Skin Lesions Associated With Insect\u2010Induced Anaphylaxis Shows Unique Features Versus Other Indolent SM","volume":"133","author":"Alvarez\u2010Twose I.","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"e_1_2_12_94_1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI Guidelines on Allergen Immunotherapy: Hymenoptera Venom Allergy","volume":"73","author":"Sturm G. J.","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"e_1_2_12_95_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher Mast Cell Load Decreases the Risk of Hymenoptera Venom\u2010Induced Anaphylaxis in Patients With Mastocytosis","volume":"132","author":"Anrooij B.","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"e_1_2_12_96_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/all.12850","article-title":"Added Sensitivity of Component\u2010Resolved Diagnosis in Hymenoptera Venom\u2010Allergic Patients With Elevated Serum Tryptase and\/or Mastocytosis","volume":"71","author":"Michel J.","year":"2016","journal-title":"Allergy"},{"issue":"4","key":"e_1_2_12_97_1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaip.2017.11.025","article-title":"Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should be Suspected","volume":"6","author":"Bonadonna P.","year":"2018","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"1","key":"e_1_2_12_98_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of Side Effects During the Buildup Phase of Venom Immunotherapy for Hymenoptera Venom Allergy: The Importance of Baseline Serum Tryptase","volume":"126","author":"Rueff F.","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"e_1_2_12_99_1","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/ijms22052586","article-title":"Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021","volume":"22","author":"Lange M.","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"e_1_2_12_100_1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","article-title":"Increased Serum Baseline Tryptase Levels and Extensive Skin Involvement Are Predictors for the Severity of Mast Cell Activation Episodes in Children With Mastocytosis","volume":"67","author":"Alvarez\u2010Twose I.","year":"2012","journal-title":"Allergy"},{"issue":"5","key":"e_1_2_12_101_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052684","article-title":"Mediator\u2010Related Symptoms and Anaphylaxis in Children With Mastocytosis","volume":"22","author":"Brockow K.","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"e_1_2_12_102_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in Patients With Mastocytosis: A Study on History, Clinical Features and Risk Factors in 120 Patients","volume":"63","author":"Brockow K.","year":"2008","journal-title":"Allergy"},{"issue":"10","key":"e_1_2_12_103_1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/all.12013","article-title":"Extensive Blistering Is a Predictor for Severe Complications in Children With Mastocytosis","volume":"67","author":"Brockow K.","year":"2012","journal-title":"Allergy"},{"issue":"1","key":"e_1_2_12_104_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaci.2015.05.008","article-title":"Clinical, Immunophenotypic, and Molecular Characteristics of Well\u2010Differentiated Systemic Mastocytosis","volume":"137","author":"Alvarez\u2010Twose I.","year":"2016","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"e_1_2_12_105_1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.anai.2021.07.004","article-title":"Symptoms of Mast Cell Activation: The Patient Perspective","volume":"127","author":"Jennings S. V.","year":"2021","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"1","key":"e_1_2_12_106_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjh.13789","article-title":"Diagnosis and Classification of Mastocytosis in Non\u2010Specialized Versus Reference Centres: A Spanish Network on Mastocytosis (REMA) Study on 122 Patients","volume":"172","author":"Sanchez\u2010Munoz L.","year":"2016","journal-title":"British Journal of Haematology"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/all.70344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/all.70344","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/all.70344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:26:22Z","timestamp":1777278382000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.70344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":105,"alternative-id":["10.1111\/all.70344"],"URL":"https:\/\/doi.org\/10.1111\/all.70344","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"2026-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"all.70344"}}